Virtu Financial’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,030
| Closed | -$5K | – | 2326 |
|
2022
Q2 | $5K | Sell |
1,030
-37
| -3% | -$180 | ﹤0.01% | 1466 |
|
2022
Q1 | $11K | Buy |
+1,067
| New | +$11K | ﹤0.01% | 1356 |
|
2021
Q4 | – | Sell |
-9,047
| Closed | -$185K | – | 2265 |
|
2021
Q3 | $185K | Buy |
+9,047
| New | +$185K | 0.02% | 944 |
|
2021
Q2 | – | Sell |
-7,317
| Closed | -$209K | – | 2162 |
|
2021
Q1 | $209K | Buy |
7,317
+6,453
| +747% | +$184K | 0.01% | 1063 |
|
2020
Q4 | $18K | Buy |
864
+239
| +38% | +$4.98K | ﹤0.01% | 1364 |
|
2020
Q3 | $16K | Sell |
625
-540
| -46% | -$13.8K | ﹤0.01% | 938 |
|
2020
Q2 | $28K | Buy |
+1,165
| New | +$28K | ﹤0.01% | 1097 |
|
2019
Q4 | – | Sell |
-3,347
| Closed | -$45K | – | 1933 |
|
2019
Q3 | $45K | Buy |
3,347
+2,212
| +195% | +$29.7K | ﹤0.01% | 1212 |
|
2019
Q2 | $16K | Buy |
+1,135
| New | +$16K | ﹤0.01% | 1348 |
|